All articles by Staff Writer
Staff Writer
Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Flagship Pioneering, the bioplatform innovation company, today announced the formation of a strategic partnership to develop and commercially scale multiproduct platforms on an accelerated basis.
Revvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCID
Innovative, easy-to-use molecular diagnostics workflow reduces complexity and costs for labs
looking to expand newborn screening capabilities
Certest completes the expansion of its new facilities
The construction of the two new buildings has represented an investment of 22 million euros
Bracco Announces Long-Term Strategic Partnership with ulrich medical for Syringeless Magnetic Resonance Injectors
The private label arrangement will bring a new syringeless magnetic resonance (MR) injector to the U.S. 510(k) premarket notification has been submitted to the U.S. Food and Drug Administration
Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders
New clinical data from Octapharma’s haematology portfolio will be presented during the scientific program at the 65th American Society of Hematology (ASH) Meeting and Exposition, which is being held on December 9–12, 2023, in San Diego, California. New data from the prospective clinical trial using wilate® for prophylaxis in patients with von Willebrand disease (VWD) will be presented. Furthermore, the design of a new phase IV clinical trial of bone and joint health in people with haemophilia A will be presented, in addition to updates from research collaborations between Octapharma and academic institutions.
Attend the Healthcare Innovation Summit Africa 2023
As technology continues to transform and disrupt every sector, the health sector is no exception. Digital innovation is having a tremendous impact on the healthcare industry from the way individuals gain access to services, to the breakthrough development of new technology that is radically transforming diagnostic procedures.
deepc Establishes MONAI Compatibility, Strengthening Its Commitment to Open-Source Collaboration and Global Healthcare Transformation
deepc, a leading MedTech company, aligns strategically with MONAI, the Medical Open Network for Artificial Intelligence. A community-driven open-source framework co-founded by NVIDIA and King’s College London, MONAI aims to advance healthcare through medical imaging. By ensuring MONAI compatibility on its platform, deepcOS, deepc emphasizes commitment to open-source AI, interoperability, and global AI development standards.
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
DxVx announces today that it will conduct its own clinical trials of OVM-200, an anti-cancer vaccine from Oxford Vacmedix(OVM) by license-in agreement and develop further with its own new drug development knowledge. Currently, the vaccine has completed a Phase 1a clinical trial in the first half of this year and is expected to start a Phase 1b trial soon.
Trillium Health Partners to become first in Canada to deploy AI in diagnostic imaging using Sectra Amplifier Services
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) helps Trillium Health Partners (THP) in Canada adopt AI technology with new AI-as-a-service agreement via Sectra Amplifier Services. This will enable THP to introduce AI-powered workflows in its diagnostic imaging department, which will help identify serious health conditions sooner, allowing for earlier intervention and better health outcomes.
Healing innovation
Chronic wounds are a major challenge worldwide. This from an economic standpoint – as managing them expends time and resources – and from a patient outcome perspective, as wounds that aren’t managed effectively can lead to significant morbidity and mortality. Professor Joachim Dissemond, MD, Department of Dermatology, Venerology and Allergology, University of Essen, Germany, is one of several academics who believe bringing more standardisation to the care of chronic wounds will improve their management, and outcomes. He tells Practical Patient Care about the M.O.I.S.T. concept developed by him and his colleagues and how it improves upon the current framework for treating wounds.